Company intelligence / Profile preview

Veritas Genetics

Danvers, Massachusetts, United Statesveritasint.com ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Veritas Genetics pioneered affordable whole genome sequencing for consumers and patients. Its flagship product "myGenome" offers comprehensive genomic analysis to assess inherited risk for diseases such as cancer and cardiovascular disorders, carrier status for recessive conditions, pharmacogenomic insights, and more. The company operates CLIA-certified labs and provides genetic counseling with its reports. In March 2022 it was acquired by LetsGetChecked to integrate genomics into at-home health testing solutions.

Modalities: Diagnostic testNext-generation sequencing (NGS)Whole genome sequencingExome sequencing
Industry: Molecular Diagnostics

Partnerships

LetsGetCheckedApposite CapitalSimcere Pharma

Beyond the preview

Go deeper on Veritas Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veritas Genetics.

Explore the full profile